陈劲松, 陈韵岱. 冠状动脉药物洗脱支架置入术后支架内再狭窄的临床研究进展[J]. 解放军医学院学报, 2014, 35(3): 292-295. DOI: 10.3969/j.issn.2095-5227.2014.03.028
引用本文: 陈劲松, 陈韵岱. 冠状动脉药物洗脱支架置入术后支架内再狭窄的临床研究进展[J]. 解放军医学院学报, 2014, 35(3): 292-295. DOI: 10.3969/j.issn.2095-5227.2014.03.028
CHEN Jing-song, CHEN Yun-dai. Advances in restenosis after drug-eluting stent implantation in coronary artery[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2014, 35(3): 292-295. DOI: 10.3969/j.issn.2095-5227.2014.03.028
Citation: CHEN Jing-song, CHEN Yun-dai. Advances in restenosis after drug-eluting stent implantation in coronary artery[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2014, 35(3): 292-295. DOI: 10.3969/j.issn.2095-5227.2014.03.028

冠状动脉药物洗脱支架置入术后支架内再狭窄的临床研究进展

Advances in restenosis after drug-eluting stent implantation in coronary artery

  • 摘要: 药物洗脱支架虽然很大程度上降低了再狭窄的发生率, 但仍有部分患者在随访期间发生再狭窄, 甚至需要再次干预病变血管。目前关于药物洗脱支架置入术后再狭窄的临床研究主要集中在预测因素、治疗上, 本文就相关临床研究的最新进展作一综述。

     

    Abstract: Drug-eluting stent(DES) can greatly decrease the incidence of restenosis,but restenosis still occurs in some patients after DES implantation,thus needing target lesion revascularization(TLR).Clinical studies at present are focused on the prediction and treatment of restenosis after DES implantation.Following is a review of its update advances.

     

/

返回文章
返回